Erratum: Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells (International Journal of Cancer (2013) 132 (2270-2282) DOI: 10.1002/ijc.27927);Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells

International Journal of Cancer

Volumn 132, Issue 10, 2013, Pages 2270-2282

  Zhu, Baoyi ^a   Li, Xiaojuan ^a   Zhang, Yuying ^b   Ye, Chunwei ^a   Wang, Yu ^a   Cai, Songwang ^a   Huang, Huaiqiu ^a   Cai, Yi ^a   Yeh, Shuyuan ^c   Huang, Zhenhua ^b   Chen, Ruihan ^a   Tao, Yiran ^a   Wen, Xingqiao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

alpha tocopherol associated protein; apoptosis; c Jun N terminal kinase; oxidative stress; prostate cancer; signal transduction

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL ASSOCIATED PROTEIN; BH3 PROTEIN; DOCETAXEL; GLUTATHIONE; HYDROGEN PEROXIDE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PARVOVIRUS VECTOR; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; MOUSE; NICK END LABELING; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS INFECTION; WESTERN BLOTTING;

EID: 84874932990     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29580     Document Type: Erratum

References (37)

1. Trachootham D, Alexandre J, Huang P,. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579-91.
2. Lau AT, Wang Y, Chiu JF,. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 2008; 104: 657-67.
3. Circu ML, Aw TY,. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749-62.
4. Benhar M, Engelberg D, Levitzki A,. ROS, stress-activated kinases and stress signaling in cancer. Embo Rep 2002; 3: 420-5.
5. Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008; 68: 1777-85.
6. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK,. Oxidative stress in prostate cancer. Cancer Lett 2009; 282: 125-36.
7. Lu J, Chew EH, Holmgren, A,. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA 2007; 104: 12288-93.
8. Alexandre J,. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006; 98: 236-44.
9. Simizu S, Takada M, Umezawa K, et al. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998; 273: 26900-7.
10. Zimmer S, Stocker A, Sarbolouki MN, et al. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem 2000; 275: 25672-80.
11. Ni J, Wen X, Yao J, et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 2005; 65: 9807-16.
12. Neuzil J, Dong LF, Wang XF, et al. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Biochem Biophys Res Commun 2006; 343: 1113-7.
13. Yamauchi J, Iwamoto T, Kida S, et al. Tocopherol-associated protein is a ligand-dependent transcriptional activator. Biochem Biophys Res Commun 2001; 285: 295-9.
14. Tang X, Yao K, Zhang L, et al. Honokiol inhibits H(2)O(2)-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways. Eur J Pharmacol 2011; 650: 72-8.
15. Martindale JL, Holbrook NJ,. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
16. Weston CR, Davis RJ,. The JNK signal transduction pathway. Curr Opin Cell Biol 2007; 19: 142-9.
17. Davis RJ,. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-52.
18. Mizumachi T, Suzuki S, Naito A, et al. Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells. Oncogene 2008; 27: 831-38.
19. Ma C, Ying C, Yuan Z, et al. dp5/HRK is a c-Jun target gene and required for apoptosis induced by potassium deprivation in cerebellar granule neurons. J Biol Chem 2007; 282: 30901-9.
20. Yamamoto K, Ichijo H, Korsmeyer SJ,. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 1999; 19: 8469-78.
21. Yanamadala V, Negoro H, Gunaratnam L, et al. Galpha12 stimulates apoptosis in epithelial cells through JNK1-mediated Bcl-2 degradation and up-regulation of IkappaBalpha. J Biol Chem 2007; 282: 24352-63.
22. Wen X, Li X, Liao B, et al. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel. Urology 2009; 73: 1407-11.
23. Wen X, Li X, Su Z, et al. Reduced expression of alpha-tocopherol- associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence. Asian J Androl 2007; 9: 206-12.
24. Gogvadze V, Norberg E, Orrenius S, et al. Involvement of Ca2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization. Int J Cancer 2010; 127: 1823-32.
25. Stapelberg M, Gellert N, Swettenham E, et al. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress. J Biol Chem 2005; 280: 25369-76.
26. Stocker A, Tomizaki T, Schulze-Briese C, et al. Crystal structure of the human supernatant protein factor. Structure 2002; 10: 1533-40.
27. Li L, Abdel FE, Cao G, et al. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling. Cancer Res 2008; 68: 434-43.
28. Kamata H, Honda S, Maeda S, et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120: 649-61.
29. Acharya A, Das I, Chandhok D, et al. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev 2010; 3: 23-34.
30. Wang J, Yi J,. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008; 7: 1875-84.
31. Grieger JC, Samulski RJ,. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 2005; 99: 119-45.
32. Aitken ML, Moss RB, Waltz DA, et al. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 2001; 12: 1907-16.
33. Arruda VR, Fields PA, Milner R, et al. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol Ther 2001; 4: 586-92.
34. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358: 2240-8.
35. Bartlett JS, Samulski RJ, McCown TJ,. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998; 9: 1181-6.
36. Fischer AC, Beck SE, Smith CI, et al. Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol Ther 2003; 8: 918-26.
37. Nicklin SA, Buening H, Dishart KL, et al. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther 2001; 4: 174-81.